Repotrectinib: NTRK fusion solid tumours: consultation records checklist

1. Provide primary tumour pathology, staging and all surgery records to assess feasible treatment pathways
2. Bring the complete NTRK fusion report and tissue available for review to confirm a true fusion
3. Organise previous TRK medicines, responses and resistance testing to investigate progression after prior treatment
4. Provide recent systemic and brain imaging, liver tests and neurological symptom records to plan initiation and maintenance monitoring

Questions to clarify
- Do I meet the eligibility criteria?
- What are the separate medical and coordination service costs without Chinese health insurance or free-drug assistance?
- How are initial treatment, ongoing treatment, return travel and follow-up arranged?
- Which risks require immediate contact with the hospital?

An initial service consultation does not replace medical assessment.